Furthermore, low levels of circulating adpN are associated with diabetes, obesity, and coronary artery disease, as well as an increased risk of acute myocardial infarction, where high levels seem to reduce overall cardiovascular risk [34]. Here, ADIPOQ is linked to acute myocardial infarction.